Omental adipose tissue: cell death |
Cell death |
ATF3, CYR61, DNAJB1, EMP1, GADD45B, HIF1A, HSPA1A, HSPA1B, ICAM1, IER3, JUN, JUNB, KLF4, MAP2K3, MCL1, MT1X, MT2A, NFIL3, NFKBIA, PBEF1, PIM1, PRG1, S100A8, SGK, TBK1, TFRC, TNFAIP3, UGCG |
Apoptosis |
ATF3, CYR61, GADD45B, HIF1A, HSPA1A, HSPA1B, ICAM1, IER3, JUN, KLF4, MAP2K3, MCL1, MT2A, NFIL3, NFKBIA, PBEF1, PIM1, PRG1, S100A8, SGK, TBK1, TFRC, TNFAIP3, UGCG |
Killing |
HSPA1A, HSPA1B, S100A8 |
Cell viability |
LMNA, MCL1, MT2A, NFKBIA, TNFAIP3, UGCG |
Cytotoxicity |
FCGR3B, MT2A, TNFAIP3 |
Survival |
CYR61, HIF1A, HSPA1B, JUN, MCL1, NFIL3, NFKBIA, PIM1, UGCG |
Colony survival |
JUN |
Inhibition |
HSPA1B, IER3, MCL1 |
Activation-induced cell death |
ICAM1 |
Subcutaneous adipose tissue: lipid metabolism |
Storage |
ADFP, GM2A, LIPA, SCD |
Quantity |
APOC1, APOE, CTSS, FCER1G, LIPA, NR1H3, PLA2G2A, SCD, UCP2, IL1RN |
Synthesis |
APOE, CD9, FCER1G, NR1H3, PLA2G2A, SCD |
Release |
CTSB, FCER1G, IL1RN, PLA2G2A |
Modification |
APOE, PLA2G2A, SCD, UCP2, ITGB2 |
Efflux |
APOE, NR1H3, SAA1 |
Hydrolysis |
GM2A, HEXB, PLA2G2A |
Accumulation |
APOE, NR1H3, IL1RN, UCP2, APOC1 |
Production |
APOE, IL1RN, ITGB2, PLA2G2A, NR1H3 |
Activation |
NR1H3 |
Esterification |
APOE, SCD |
Oxidation |
APOE, SCD, UCP2 |
Peroxidation |
APOE, PLA2G2A |
Co-capping |
ITGB2 |
Uptake |
APOC1, APOE |
Metabolism |
APOC1, APOD, IL1RN, PLA2G2A, SCD |
Exchange |
APOC1 |
Liberation |
PLA2G2A |
Degradation |
GM2A, PLA2G2A |
Desaturation |
SCD |
Secretion |
APOE, SCD |
Steroidogenesis |
APOE |
Transport |
ADFP |